• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发对接受皮质类固醇治疗的多发性硬化症患者疼痛及生活质量的影响

The Impact of Relapses on Pain and Quality of Life in Patients with Multiple Sclerosis Treated with Corticosteroids.

作者信息

Rakusa Martin, Chataway Jeremy, Hardy Todd A

机构信息

Division of Neurology, University Medical Centre Maribor, Ljubljanska 5, 2000 Maribor, Slovenia.

Faculty of Medicine, University of Maribor, Taborska 8, 2000 Maribor, Slovenia.

出版信息

Pharmaceuticals (Basel). 2023 Sep 4;16(9):1244. doi: 10.3390/ph16091244.

DOI:10.3390/ph16091244
PMID:37765052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10536772/
Abstract

BACKGROUND

We assessed the prevalence and risks associated with pain during and after a multiple sclerosis (MS) relapse, and the impact of pain on quality of life (QoL), in MS patients.

METHODS

117 patients suffering an acute MS relapse were evaluated with clinician- and patient-reported outcomes, including the expanded disability status scale (EDSS), Multiple Sclerosis Impact Scale (MSIS-29), and MS Walking scale-12 (MSWS-12). Relapse-related pain was assessed via the short-form 36 (SF-36) questionnaire upon first visit (relapse onset) and at 6 weeks after treatment with intravenous methylprednisolone (follow-up visit).

RESULTS

Pain was present in 80% of patients at relapse onset. Patients with pain were more impaired physically (higher mean scores on MSIS-29 and MSWS-12 and lower mean scores on SF-36 role physical, physical, and vitality scales) at relapse and six weeks after. In total, 74% of patients with MS relapse reported a poorer QoL due to pain. A lower psychological well-being was correlated with greater pain (MSIS29 score). An increased number of prior relapses was a predictor of more pain at relapse onset.

CONCLUSIONS

Pain was common at the time of MS relapse and improved, but was still significant, six weeks after treatment with corticosteroids. Further studies are required to better understand relapse-related pain.

摘要

背景

我们评估了多发性硬化症(MS)复发期间及复发后疼痛的患病率、相关风险,以及疼痛对MS患者生活质量(QoL)的影响。

方法

对117例急性MS复发患者进行了临床医生和患者报告结局的评估,包括扩展残疾状态量表(EDSS)、多发性硬化症影响量表(MSIS-29)和MS步行量表-12(MSWS-12)。在首次就诊(复发开始)时和静脉注射甲泼尼龙治疗6周后(随访就诊),通过简短健康调查问卷36(SF-36)评估与复发相关的疼痛。

结果

80%的患者在复发开始时存在疼痛。有疼痛的患者在复发时及复发后6周身体功能受损更严重(MSIS-29和MSWS-12的平均得分更高,SF-36角色身体、身体和活力量表的平均得分更低)。总体而言,74%的MS复发患者报告因疼痛导致生活质量较差。较低的心理健康与更严重的疼痛相关(MSIS29评分)。既往复发次数增加是复发开始时疼痛更严重的一个预测因素。

结论

MS复发时疼痛很常见,且在使用皮质类固醇治疗6周后有所改善,但仍很显著。需要进一步研究以更好地了解与复发相关的疼痛。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4431/10536772/a34d05307121/pharmaceuticals-16-01244-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4431/10536772/a34d05307121/pharmaceuticals-16-01244-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4431/10536772/a34d05307121/pharmaceuticals-16-01244-g001.jpg

相似文献

1
The Impact of Relapses on Pain and Quality of Life in Patients with Multiple Sclerosis Treated with Corticosteroids.复发对接受皮质类固醇治疗的多发性硬化症患者疼痛及生活质量的影响
Pharmaceuticals (Basel). 2023 Sep 4;16(9):1244. doi: 10.3390/ph16091244.
2
Erratum.勘误
Mult Scler. 2016 Oct;22(12):NP9-NP11. doi: 10.1177/1352458515585718. Epub 2015 Jun 3.
3
Mitoxantrone: a review of its use in multiple sclerosis.米托蒽醌:其在多发性硬化症中的应用综述
CNS Drugs. 2004;18(6):379-96. doi: 10.2165/00023210-200418060-00010.
4
Premorbid Sociodemographic Status and Multiple Sclerosis Outcomes in a Universal Health Care Context.普遍医疗保健背景下的发病前社会人口统计学状况与多发性硬化症结局。
JAMA Netw Open. 2023 Sep 5;6(9):e2334675. doi: 10.1001/jamanetworkopen.2023.34675.
5
Validation of the Korean Version of the 12-Item Multiple Sclerosis Walking Scale and Application to Neuromyelitis Optica Spectrum Disorder.12项多发性硬化症步行量表韩文版的验证及其在视神经脊髓炎谱系障碍中的应用。
J Clin Neurol. 2020 Apr;16(2):270-276. doi: 10.3988/jcn.2020.16.2.270.
6
Pregnancy in multiple sclerosis: clinical and self-report scales.多发性硬化症患者妊娠:临床和自我报告量表。
J Neurol. 2012 Feb;259(2):311-7. doi: 10.1007/s00415-011-6186-7. Epub 2011 Aug 3.
7
Quantifying the impact of upper limb tremor on the quality of life of people with multiple sclerosis: a comparison between the QUEST and MSIS-29 scales.定量评估多发性硬化症患者上肢震颤对其生活质量的影响:QUEST 量表和 MSIS-29 量表的比较。
Mult Scler Relat Disord. 2022 Feb;58:103495. doi: 10.1016/j.msard.2022.103495. Epub 2022 Jan 4.
8
Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine.评估多发性硬化症患者自我报告行走能力的临床有意义改善:来自延长释放型苯丙胺的随机、双盲、III 期 ENHANCE 试验的结果。
CNS Drugs. 2019 Jan;33(1):61-79. doi: 10.1007/s40263-018-0586-5.
9
A Prospective Observational Registry of Repository Corticotropin Injection (Acthar® Gel) for the Treatment of Multiple Sclerosis Relapse.一项关于储存型促肾上腺皮质激素注射液(Acthar® Gel)治疗多发性硬化症复发的前瞻性观察性登记研究。
Front Neurol. 2020 Dec 22;11:598496. doi: 10.3389/fneur.2020.598496. eCollection 2020.
10
Variability of Multiple Sclerosis Walking Scale and Multiple Sclerosis Impact Scale Scores in People Without Multiple Sclerosis.无多发性硬化症人群的多发性硬化症步行量表及多发性硬化症影响量表评分的变异性
Cureus. 2024 Jan 7;16(1):e51811. doi: 10.7759/cureus.51811. eCollection 2024 Jan.

本文引用的文献

1
Joint European Academy of Neurology-European Pain Federation-Neuropathic Pain Special Interest Group of the International Association for the Study of Pain guidelines on neuropathic pain assessment.欧洲神经病学学会-欧洲疼痛联合会-国际疼痛研究协会神经病理性疼痛特别兴趣小组关于神经病理性疼痛评估的指南。
Eur J Neurol. 2023 Aug;30(8):2177-2196. doi: 10.1111/ene.15831. Epub 2023 May 30.
2
Evaluation of Neuropathic Extremity Pain in Patients with Multiple Sclerosis.多发性硬化症患者神经性肢体疼痛的评估
Noro Psikiyatr Ars. 2019 Oct 4;58(3):213-216. doi: 10.29399/npa.24802. eCollection 2021.
3
Pain Intensity and Pain Interference in People With Progressive Multiple Sclerosis Compared With People With Relapsing-Remitting Multiple Sclerosis.
与复发缓解型多发性硬化症患者相比,进展型多发性硬化症患者的疼痛强度和疼痛干扰情况。
Arch Phys Med Rehabil. 2021 Oct;102(10):1959-1964. doi: 10.1016/j.apmr.2021.05.003. Epub 2021 May 25.
4
Differences in physical, mental, and social functions between males and females in multiple sclerosis: A multicenter cross-sectional study in China.多发性硬化症中男性与女性的身体、心理和社会功能差异:一项在中国开展的多中心横断面研究
Mult Scler Relat Disord. 2021 Feb;48:102693. doi: 10.1016/j.msard.2020.102693. Epub 2020 Dec 19.
5
Quality of life in adults with multiple sclerosis: a systematic review.多发性硬化症成人患者的生活质量:系统评价。
BMJ Open. 2020 Nov 30;10(11):e041249. doi: 10.1136/bmjopen-2020-041249.
6
Pain Characteristics and Associations with Quality of Life in Patients with Multiple Sclerosis in Lithuania.立陶宛多发性硬化症患者的疼痛特征及其与生活质量的关联
Medicina (Kaunas). 2020 Nov 8;56(11):596. doi: 10.3390/medicina56110596.
7
Prevalence And Impact Of Myofascial Pain Syndrome In Relapsing-Remitting Multiple Sclerosis And The Effects Of Local Anesthetic Injections For Short-Term Treatment.复发性缓解型多发性硬化症中肌筋膜疼痛综合征的患病率及影响以及局部麻醉注射短期治疗的效果
Mult Scler Relat Disord. 2020 Nov;46:102528. doi: 10.1016/j.msard.2020.102528. Epub 2020 Sep 26.
8
[The influence of multiple sclerosis-related symptoms on health-related quality of life].[多发性硬化相关症状对健康相关生活质量的影响]
Fortschr Neurol Psychiatr. 2020 Nov;88(11):704-712. doi: 10.1055/a-1113-7702. Epub 2020 Apr 30.
9
Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study.多发性硬化症中疼痛的纵向患病率及其决定因素:来自德国国家多发性硬化症队列研究的结果。
Pain. 2020 Apr;161(4):787-796. doi: 10.1097/j.pain.0000000000001767.
10
Prevalence of pain in patients with multiple sclerosis and its association with anxiety, depressive symptoms and quality of life.多发性硬化症患者疼痛的患病率及其与焦虑、抑郁症状和生活质量的关联。
Psychiatr Pol. 2019 Apr 30;53(2):475-486. doi: 10.12740/PP/94469.